-
公开(公告)号:US20100021405A1
公开(公告)日:2010-01-28
申请号:US12445177
申请日:2007-10-11
申请人: Masamichi Abe , Ayako Harada , Yoichi Honma
发明人: Masamichi Abe , Ayako Harada , Yoichi Honma
CPC分类号: A61K9/0014 , A61K8/34 , A61K8/553 , A61K47/10 , A61K47/24 , A61Q7/00 , A61Q17/02 , A61Q19/08
摘要: The present invention provides an external preparation for skin comprising a phospholipid having an iodine value of 80 to 110, ethanol in an amount of 55 to 83 wt % and water in an amount of 15 to 43 wt %, which is improved in it's preparation stability by suppressing an increase in an acid value of phospholipid. The present invention also provides an external preparation for skin which is improved in percutaneous absorption of medically effective ingredient(s). The present invention provides further a method for suppressing an increase in an acid value of phospholipid by comprising phospholipid having high iodine value and high concentration of ethanol and water, as well as a method for improving percutaneous absorption of medically effective ingredient(s) in external preparation for skin.
摘要翻译: 本发明提供一种皮肤外用剂,其含有碘值为80〜110的磷脂,乙醇为55〜83重量%,水为15〜43重量%,其制备稳定性提高 通过抑制磷脂酸值的增加。 本发明还提供了皮肤外用剂,其经皮吸收医药上有效成分得到改善。 本发明还提供了一种抑制磷脂酸值增加的方法,其包括具有高碘值和高浓度乙醇和水的磷脂,以及用于改善外部药物有效成分的经皮吸收的方法 皮肤准备
-
公开(公告)号:US20080207560A1
公开(公告)日:2008-08-28
申请号:US11794298
申请日:2006-01-06
申请人: Ayako Harada , Yoichi Honma , Masamichi Abe
发明人: Ayako Harada , Yoichi Honma , Masamichi Abe
IPC分类号: A61K31/715 , A61K47/14 , A61K31/07 , A61K31/375 , A61K31/52 , A61K8/35 , A61P17/00
CPC分类号: A61K9/0014 , A61K8/34 , A61K8/355 , A61K8/494 , A61K8/553 , A61K8/671 , A61K8/676 , A61K8/735 , A61K31/07 , A61K31/375 , A61K31/52 , A61K31/715 , A61Q19/00
摘要: An object of the present invention is to provide a composition for external use in which the percutaneous absorbability of vitamin A, vitamin A derivative(s), vitamin C, specific vitamin C derivative(s), xanthine derivative(s), ubiquinone(s) and/or hyaluronic acid is improved.The composition for external use is prepared by blending (i) a phospholipid and (ii) a mono- or oligo-glycol ether, together with (iv) at least one bioactive component selected from the group consisting of hyaluronic acid, hyaluronic acid derivatives, vitamin A, vitamin A derivatives, vitamin C, specific vitamin C derivatives, xanthine derivatives, ubiquinones, and salts thereof.
摘要翻译: 本发明的目的是提供一种外用组合物,其中维生素A,维生素A衍生物,维生素C,特定维生素C衍生物,黄嘌呤衍生物,泛醌(s)的经皮吸收性 )和/或透明质酸得到改善。 外用组合物通过将(i)磷脂和(ii)单 - 或二聚乙二醇醚与(iv)至少一种选自透明质酸,透明质酸衍生物, 维生素A,维生素A衍生物,维生素C,特定维生素C衍生物,黄嘌呤衍生物,泛醌及其盐。
-
公开(公告)号:US07989590B2
公开(公告)日:2011-08-02
申请号:US11886724
申请日:2006-03-17
CPC分类号: C07K5/0808 , A61K38/00 , C07K5/101 , C07K7/06
摘要: The present invention relates to a novel peptide having a specified amino acid sequence or its derivative, or a salt thereof. Further, the present invention relates to a composition containing the novel peptide or the like, a method of utilizing the novel peptide or the like, use of the novel peptide or the like, a polynucleotide encoding the novel peptide, or the like. The novel peptide of the present invention or its derivative, or a salt thereof can be utilized for enhancing production of at least one member selected from the group consisting of collagen and hyaluronic acid in a cell.
摘要翻译: 本发明涉及具有特定氨基酸序列或其衍生物的新型肽或其盐。 此外,本发明涉及含有新肽等的组合物,利用新肽等的方法,新肽等的用途,编码新肽的多核苷酸等。 本发明的新肽或其衍生物或其盐可用于增强细胞中选自胶原蛋白和透明质酸的至少一种成分的产生。
-
公开(公告)号:US06569903B2
公开(公告)日:2003-05-27
申请号:US09890899
申请日:2001-11-14
IPC分类号: A61K31135
CPC分类号: A61K31/4704 , A61K9/0048 , A61K31/00 , A61K31/137 , A61K31/44
摘要: Ophthalmic compositions having negligible side effects on the heart can be obtained by using as the active ingredient an adrenergic &bgr; receptor agonist having a high selectivity toward adrenergic &bgr;2 receptor. These compositions are usable as preventives or therapeutics for xerophthalmic disorder and keratoconjunctival disorder.
摘要翻译: 通过使用对肾上腺素β2受体具有高选择性的肾上腺素能β受体激动剂作为活性成分,可以获得对心脏具有可忽略的副作用的眼用组合物。 这些组合物可用作干眼症和角膜结膜疾病的预防剂或治疗剂。
-
公开(公告)号:US20090209728A1
公开(公告)日:2009-08-20
申请号:US11886724
申请日:2006-03-17
CPC分类号: C07K5/0808 , A61K38/00 , C07K5/101 , C07K7/06
摘要: The present invention relates to a novel peptide having a specified amino acid sequence or its derivative, or a salt thereof. Further, the present invention relates to a composition containing the novel peptide or the like, a method of utilizing the novel peptide or the like, use of the novel peptide or the like, a polynucleotide encoding the novel peptide, or the like. The novel peptide of the present invention or its derivative, or a salt thereof can be utilized for enhancing production of at least one member selected from the group consisting of collagen and hyaluronic acid in a cell.
摘要翻译: 本发明涉及具有特定氨基酸序列或其衍生物的新型肽或其盐。 此外,本发明涉及含有新肽等的组合物,利用新肽等的方法,新肽等的用途,编码新肽的多核苷酸等。 本发明的新肽或其衍生物或其盐可用于增强细胞中选自胶原蛋白和透明质酸的至少一种成分的产生。
-
公开(公告)号:US20090054346A1
公开(公告)日:2009-02-26
申请号:US11859545
申请日:2007-09-21
摘要: An objective of the present invention is to provide novel useful elastin production-enhancing agents that have a remarkable ability to enhance elastin production. The present invention provides elastin production-enhancing agents that include at least one component selected from the group consisting of the peptide Leu-Glu-His-Ala (formula I; SEQ ID NO:1), derivatives of the peptide, and salts thereof. The present invention also provides elastin production-enhancing agents that include at least one component selected from the group consisting of peptides which include a conservative substitution, deletion, and/or addition of one or more amino acids in the amino acid sequence of formula I that retain an ability to enhance elastin production in cells; derivatives of such peptides; and salts thereof.
摘要翻译: 本发明的目的是提供具有显着增强弹性蛋白生产能力的新型有用的弹性蛋白生产增强剂。 本发明提供弹性蛋白生产增强剂,其包括选自肽Leu-Glu-His-Ala(式I; SEQ ID NO:1),肽衍生物及其盐中的至少一种成分。 本发明还提供了弹性蛋白生产增强剂,其包括至少一种选自包括在式I的氨基酸序列中的一个或多个氨基酸的保守取代,缺失和/或添加的肽的组分, 保持增强细胞弹性蛋白生产的能力; 这些肽的衍生物; 及其盐。
-
-
-
-
-